Global Anatomic Pathology Market Size, Status and Forecast 2020-2026

Published On: Sep 2020

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 238019

Anatomic Pathology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anatomic Pathology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Agilent Technologies, Inc.
Bio SB
Biogenex Laboratories
Danaher Corporation
F. Hoffmann-La Roche AG.
Laboratory Corporation of America Holdings
Neogenomics Laboratories, Inc.
Quest Diagnostics Incorporated
Sakura Finetechnical Co., Ltd.
Thermo Fisher Scientific, Inc.

Market segment by Type, the product can be split into
Instruments
Consumables
Market segment by Application, split into
Histopathology
Cytopathology

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anatomic Pathology Revenue
1.4 Market by Type
1.4.1 Global Anatomic Pathology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Anatomic Pathology Market Share by Application: 2020 VS 2026
1.5.2 Histopathology
1.5.3 Cytopathology
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Anatomic Pathology Market Perspective (2015-2026)
2.2 Global Anatomic Pathology Growth Trends by Regions
2.2.1 Anatomic Pathology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anatomic Pathology Historic Market Share by Regions (2015-2020)
2.2.3 Anatomic Pathology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anatomic Pathology Market Growth Strategy
2.3.6 Primary Interviews with Key Anatomic Pathology Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Anatomic Pathology Players by Market Size
3.1.1 Global Top Anatomic Pathology Players by Revenue (2015-2020)
3.1.2 Global Anatomic Pathology Revenue Market Share by Players (2015-2020)
3.1.3 Global Anatomic Pathology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anatomic Pathology Market Concentration Ratio
3.2.1 Global Anatomic Pathology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anatomic Pathology Revenue in 2019
3.3 Anatomic Pathology Key Players Head office and Area Served
3.4 Key Players Anatomic Pathology Product Solution and Service
3.5 Date of Enter into Anatomic Pathology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Anatomic Pathology Historic Market Size by Type (2015-2020)
4.2 Global Anatomic Pathology Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Anatomic Pathology Market Size by Application (2015-2020)
5.2 Global Anatomic Pathology Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Anatomic Pathology Market Size (2015-2020)
6.2 Anatomic Pathology Key Players in North America (2019-2020)
6.3 North America Anatomic Pathology Market Size by Type (2015-2020)
6.4 North America Anatomic Pathology Market Size by Application (2015-2020)

7 Europe
7.1 Europe Anatomic Pathology Market Size (2015-2020)
7.2 Anatomic Pathology Key Players in Europe (2019-2020)
7.3 Europe Anatomic Pathology Market Size by Type (2015-2020)
7.4 Europe Anatomic Pathology Market Size by Application (2015-2020)

8 China
8.1 China Anatomic Pathology Market Size (2015-2020)
8.2 Anatomic Pathology Key Players in China (2019-2020)
8.3 China Anatomic Pathology Market Size by Type (2015-2020)
8.4 China Anatomic Pathology Market Size by Application (2015-2020)

9 Japan
9.1 Japan Anatomic Pathology Market Size (2015-2020)
9.2 Anatomic Pathology Key Players in Japan (2019-2020)
9.3 Japan Anatomic Pathology Market Size by Type (2015-2020)
9.4 Japan Anatomic Pathology Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Anatomic Pathology Market Size (2015-2020)
10.2 Anatomic Pathology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anatomic Pathology Market Size by Type (2015-2020)
10.4 Southeast Asia Anatomic Pathology Market Size by Application (2015-2020)

11 India
11.1 India Anatomic Pathology Market Size (2015-2020)
11.2 Anatomic Pathology Key Players in India (2019-2020)
11.3 India Anatomic Pathology Market Size by Type (2015-2020)
11.4 India Anatomic Pathology Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Anatomic Pathology Market Size (2015-2020)
12.2 Anatomic Pathology Key Players in Central & South America (2019-2020)
12.3 Central & South America Anatomic Pathology Market Size by Type (2015-2020)
12.4 Central & South America Anatomic Pathology Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Agilent Technologies, Inc.
13.1.1 Agilent Technologies, Inc. Company Details
13.1.2 Agilent Technologies, Inc. Business Overview
13.1.3 Agilent Technologies, Inc. Anatomic Pathology Introduction
13.1.4 Agilent Technologies, Inc. Revenue in Anatomic Pathology Business (2015-2020))
13.1.5 Agilent Technologies, Inc. Recent Development
13.2 Bio SB
13.2.1 Bio SB Company Details
13.2.2 Bio SB Business Overview
13.2.3 Bio SB Anatomic Pathology Introduction
13.2.4 Bio SB Revenue in Anatomic Pathology Business (2015-2020)
13.2.5 Bio SB Recent Development
13.3 Biogenex Laboratories
13.3.1 Biogenex Laboratories Company Details
13.3.2 Biogenex Laboratories Business Overview
13.3.3 Biogenex Laboratories Anatomic Pathology Introduction
13.3.4 Biogenex Laboratories Revenue in Anatomic Pathology Business (2015-2020)
13.3.5 Biogenex Laboratories Recent Development
13.4 Danaher Corporation
13.4.1 Danaher Corporation Company Details
13.4.2 Danaher Corporation Business Overview
13.4.3 Danaher Corporation Anatomic Pathology Introduction
13.4.4 Danaher Corporation Revenue in Anatomic Pathology Business (2015-2020)
13.4.5 Danaher Corporation Recent Development
13.5 F. Hoffmann-La Roche AG.
13.5.1 F. Hoffmann-La Roche AG. Company Details
13.5.2 F. Hoffmann-La Roche AG. Business Overview
13.5.3 F. Hoffmann-La Roche AG. Anatomic Pathology Introduction
13.5.4 F. Hoffmann-La Roche AG. Revenue in Anatomic Pathology Business (2015-2020)
13.5.5 F. Hoffmann-La Roche AG. Recent Development
13.6 Laboratory Corporation of America Holdings
13.6.1 Laboratory Corporation of America Holdings Company Details
13.6.2 Laboratory Corporation of America Holdings Business Overview
13.6.3 Laboratory Corporation of America Holdings Anatomic Pathology Introduction
13.6.4 Laboratory Corporation of America Holdings Revenue in Anatomic Pathology Business (2015-2020)
13.6.5 Laboratory Corporation of America Holdings Recent Development
13.7 Neogenomics Laboratories, Inc.
13.7.1 Neogenomics Laboratories, Inc. Company Details
13.7.2 Neogenomics Laboratories, Inc. Business Overview
13.7.3 Neogenomics Laboratories, Inc. Anatomic Pathology Introduction
13.7.4 Neogenomics Laboratories, Inc. Revenue in Anatomic Pathology Business (2015-2020)
13.7.5 Neogenomics Laboratories, Inc. Recent Development
13.8 Quest Diagnostics Incorporated
13.8.1 Quest Diagnostics Incorporated Company Details
13.8.2 Quest Diagnostics Incorporated Business Overview
13.8.3 Quest Diagnostics Incorporated Anatomic Pathology Introduction
13.8.4 Quest Diagnostics Incorporated Revenue in Anatomic Pathology Business (2015-2020)
13.8.5 Quest Diagnostics Incorporated Recent Development
13.9 Sakura Finetechnical Co., Ltd.
13.9.1 Sakura Finetechnical Co., Ltd. Company Details
13.9.2 Sakura Finetechnical Co., Ltd. Business Overview
13.9.3 Sakura Finetechnical Co., Ltd. Anatomic Pathology Introduction
13.9.4 Sakura Finetechnical Co., Ltd. Revenue in Anatomic Pathology Business (2015-2020)
13.9.5 Sakura Finetechnical Co., Ltd. Recent Development
13.10 Thermo Fisher Scientific, Inc.
13.10.1 Thermo Fisher Scientific, Inc. Company Details
13.10.2 Thermo Fisher Scientific, Inc. Business Overview
13.10.3 Thermo Fisher Scientific, Inc. Anatomic Pathology Introduction
13.10.4 Thermo Fisher Scientific, Inc. Revenue in Anatomic Pathology Business (2015-2020)
13.10.5 Thermo Fisher Scientific, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details